The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
How does COVID-19 affect the outcomes of patients with acute myeloid leukemia?
Olga Gavrilina
June 18, 2021
During the EHA2021 Virtual Congress, Know AML spoke with Olga Gavrilina, National Research Center for Hematology, Moscow, RU. We asked, How does COVID-19 affect the outcomes of patients with acute myeloid leukemia? In this video, Gavrilina discusses the complications, therapy options, prognosis, vaccination, and the possibility of reinfection for patients diagnosed with acute myeloid leukemia and COVID-19 infection.
To what extent do you agree with the following statements?
Please rate between 1 and 5, with 1 being 'strongly disagree' and 5 being 'strongly agree'.
